CUSIP No. M68830104
|
13G
|
Page 2 of 9 Pages
|
1 | NAME OF REPORTING PERSONS
Clal Industries Ltd.
|
||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) o
(b) o
|
||
3 |
SEC USE ONLY
|
||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5 | SOLE VOTING POWER
---
|
|
6 | SHARED VOTING POWER
9,389,555 (*)
|
||
7 | SOLE DISPOSITIVE POWER
---
|
||
8 | SHARED DISPOSITIVE POWER
9,389,555 (*)
|
||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,389,555 (*)
|
||
10 |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
o
|
||
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
42.82% (*) (**)
|
||
12 |
TYPE OF REPORTING PERSON (See instructions)
CO
|
CUSIP No. M68830104
|
13G
|
Page 3 of 9 Pages
|
1 | NAME OF REPORTING PERSONS
Clal Biotechnology Industries Ltd.
|
||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) o
(b) o
|
||
3 |
SEC USE ONLY
|
||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5 | SOLE VOTING POWER
---
|
|
6 | SHARED VOTING POWER
9,389,555 (*)
|
||
7 | SOLE DISPOSITIVE POWER
---
|
||
8 | SHARED DISPOSITIVE POWER
9,389,555 (*)
|
||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,389,555 (*)
|
||
10 |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
o
|
||
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
42.82% (*) (**)
|
||
12 |
TYPE OF REPORTING PERSON (See instructions)
CO
|
CUSIP No. M68830104
|
13G
|
Page 4 of 9 Pages
|
1 | NAME OF REPORTING PERSONS
Clal Life Sciences L.P
|
||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) o
(b) o
|
||
3 |
SEC USE ONLY
|
||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5 | SOLE VOTING POWER
---
|
|
6 | SHARED VOTING POWER
8,208,973 (*)
|
||
7 | SOLE DISPOSITIVE POWER
---
|
||
8 | SHARED DISPOSITIVE POWER
8,208,973 (*)
|
||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,208,973 (*)
|
||
10 |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
o
|
||
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
37.43% (*) (**)
|
||
12 |
TYPE OF REPORTING PERSON (See instructions)
PN
|
Item 1.
|
(a) |
Name of Issuer:
|
(b)
|
Address of Issuer's Principal Executive Offices:
|
Item 2.
|
(a) |
Name of Person Filing:
|
(b)
|
Address of Principal Business Office:
|
(c)
|
Citizenship:
|
(d)
|
Title of Class of Securities:
|
(e)
|
CUSIP Number:
|
Item 3.
|
Not applicable
|
Item 4.
|
Ownership:
|
(a)
|
Amount beneficially owned:
|
·
|
1,180,582 Ordinary Shares (representing 5.38% of the total Ordinary Shares outstanding) are owned directly by Clal Biotechnology Industries Ltd. ("CBI").
|
·
|
8,208,973 Ordinary Shares (representing 37.43% of the total Ordinary Shares outstanding) are owned directly by Clal Life Sciences L.P. ("Life Sciences").
|
(b)
|
Percent of class:
|
(c)
|
Number of shares as to which such person has:
|
(i)
|
Sole power to vote or to direct the vote:
|
(ii)
|
Shared power to vote or to direct the vote:
|
(iii)
|
Sole power to dispose or to direct the disposition of:
|
(iv)
|
Shared power to dispose or to direct the disposition of:
|
Item 5.
|
Ownership of Five Percent or Less of a Class:
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another:
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
|
Item 8.
|
Identification and Classification of Members of the Group:
|
Item 9.
|
|
Notice of Dissolution of Group:
|
Item 10.
|
Certification:
|
Clal Industries Ltd.
/s/ Yehuda Ben Ezra
By: Yehuda Ben Ezra
Title: VP Comptroller
/s/ Nufar Malovani
By: Nufar Malovani
Title: VP General Counsel & Corporate Secretary
Clal Biotechnology Industries Ltd.
/s/ Ofer Goldberg
By: Ofer Goldberg
Title: VP
/s/ Assaf Segal
By: Assaf Segal
Title: CFO
Clal Life Sciences L.P
/s/ Moti Hacham
By Clal Application Center Ltd. (G.P.)By: Moti Hacham
Title: Authorized signatory
/s/ Assaf Segal
By Clal Application Center Ltd. (G.P.)
By: Assaf Segal
Title: Director
|
EXHIBIT NO.
|
DESCRIPTION
|
Exhibit 1
|
Agreement of Joint Filing by and among the Reporting Persons, dated as of February 12, 2015 (incorporated herein by reference to Exhibit 1 to the Schedule 13G filed on February 12, 2015).
|